329 related articles for article (PubMed ID: 23202501)
1. Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines.
Zhang J
Viruses; 2012 Nov; 4(11):2711-35. PubMed ID: 23202501
[TBL] [Abstract][Full Text] [Related]
2. [Study on the immunogenicity of adeno-vector vaccine against H5N1 influenza A virus].
Zhang XG; Li KB; Ma J; Wang NF; Zhang XM; Sang YH; Dong J; Xu H; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):97-9. PubMed ID: 20104746
[TBL] [Abstract][Full Text] [Related]
3. A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses.
Hoelscher MA; Singh N; Garg S; Jayashankar L; Veguilla V; Pandey A; Matsuoka Y; Katz JM; Donis R; Mittal SK; Sambhara S
J Infect Dis; 2008 Apr; 197(8):1185-8. PubMed ID: 18462165
[TBL] [Abstract][Full Text] [Related]
4. Coadministration of Recombinant Adenovirus Expressing GM-CSF with Inactivated H5N1 Avian Influenza Vaccine Increased the Immune Responses and Protective Efficacy Against a Wild Bird Source of H5N1 Challenge.
Wang X; Wang X; Jia Y; Wang C; Tang Q; Han Q; Xiao S; Yang Z
J Interferon Cytokine Res; 2017 Oct; 37(10):467-473. PubMed ID: 29028432
[TBL] [Abstract][Full Text] [Related]
5. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.
Wang J; Ge A; Xu M; Wang Z; Qiao Y; Gu Y; Liu C; Liu Y; Hou J
Virol J; 2015 Aug; 12():126. PubMed ID: 26263920
[TBL] [Abstract][Full Text] [Related]
6. Production of adenovirus vectors and their use as a delivery system for influenza vaccines.
Vemula SV; Mittal SK
Expert Opin Biol Ther; 2010 Oct; 10(10):1469-87. PubMed ID: 20822477
[TBL] [Abstract][Full Text] [Related]
7. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.
Gao W; Soloff AC; Lu X; Montecalvo A; Nguyen DC; Matsuoka Y; Robbins PD; Swayne DE; Donis RO; Katz JM; Barratt-Boyes SM; Gambotto A
J Virol; 2006 Feb; 80(4):1959-64. PubMed ID: 16439551
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral vector expressing murine β-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice.
Vemula SV; Pandey A; Singh N; Katz JM; Donis R; Sambhara S; Mittal SK
Virus Res; 2013 Oct; 177(1):55-61. PubMed ID: 23892144
[TBL] [Abstract][Full Text] [Related]
9. Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.
Mooney AJ; Li Z; Gabbard JD; He B; Tompkins SM
J Virol; 2013 Jan; 87(1):363-71. PubMed ID: 23077318
[TBL] [Abstract][Full Text] [Related]
10. [Protective properties of candidate genetically engineered vaccines against avian influenza viruses constructed on the basis of recombinant adenoviral vectors].
Sedova ES; Shmarov MM; Tutykhina IL; Barykova IuA; Verkhovskaia LV; Logunov DIu; Naroditskiĭ BS; Gintsburg AL
Zh Mikrobiol Epidemiol Immunobiol; 2010; (3):44-8. PubMed ID: 20734718
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
12. Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines.
Kim SH; Samal SK
Viruses; 2019 Mar; 11(3):. PubMed ID: 30917500
[TBL] [Abstract][Full Text] [Related]
13. Designing vaccines for pandemic influenza.
Horimoto T; Kawaoka Y
Curr Top Microbiol Immunol; 2009; 333():165-76. PubMed ID: 19768405
[TBL] [Abstract][Full Text] [Related]
14. Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.
Toro H; Tang DC; Suarez DL; Sylte MJ; Pfeiffer J; Van Kampen KR
Vaccine; 2007 Apr; 25(15):2886-91. PubMed ID: 17055126
[TBL] [Abstract][Full Text] [Related]
15. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines.
Tang DC; Zhang J; Toro H; Shi Z; Van Kampen KR
Expert Rev Vaccines; 2009 Apr; 8(4):469-81. PubMed ID: 19348562
[TBL] [Abstract][Full Text] [Related]
17. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
18. Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.
Zheng D; Yi Y; Chen Z
Viruses; 2012 Dec; 4(12):3589-605. PubMed ID: 23223214
[TBL] [Abstract][Full Text] [Related]
19. A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge.
Shirvani E; Varghese BP; Paldurai A; Samal SK
Sci Rep; 2020 Feb; 10(1):2221. PubMed ID: 32042001
[TBL] [Abstract][Full Text] [Related]
20. [Immunological evaluation of vector-expressed M2 and HA genes of H5N1 influenza virus in mice].
Guo J; Yao L; Chen A; Xu Y; Liu X; Shu Y; Zhang Z
Sheng Wu Gong Cheng Xue Bao; 2010 May; 26(5):649-56. PubMed ID: 20684310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
